Andreas Hutloff

Prof. Dr. Andreas Hutloff

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1999 in Nature
Verified
Journal Article
Closed access
PDF file
AHAndreas Hutloff
Andreas Hutloff
ADAnna M. Dittrich
Anna M. Dittrich
KBKatja C. Beier
Katja C. Beier
BEBarbara Eljaschewitsch
Barbara Eljaschewitsch
RKRegine Kraft
Regine Kraft
RKRichard A. Kroczek
Richard A. Kroczek

10 February 2003 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
BGBodo Grimbacher
Bodo Grimbacher
AHAndreas Hutloff
Andreas Hutloff
MSMichael Schlesier
Michael Schlesier
EGErik Glocker
Erik Glocker
KWKlaus Warnatz
Klaus Warnatz
HPHans H. Peter
Hans H. Peter

1 November 2009 in Immunity
Verified
Journal Article
Closed access
BDBrigitte G. Dorner
Brigitte G. Dorner
MDMartin B. Dorner
Martin B. Dorner
XZXuefei Zhou
Xuefei Zhou
COCorinna Opitz
Corinna Opitz
AMAhmed Mora
Ahmed Mora
RKRichard A. Kroczek
Richard A. Kroczek

8 November 2007 in Nature
Verified
Journal Article
Closed access
PDF file
DYDi Yu
Di Yu
ATAndy Hee-Meng Tan
Andy Hee-Meng Tan
XHXin Hu
Xin Hu
VAVicki Athanasopoulos
Vicki Athanasopoulos
NSNicholas Simpson
Nicholas Simpson
CVCarola G. Vinuesa
Carola G. Vinuesa

2 February 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JWJan P. Weber
Jan P. Weber
FFFranziska Fuhrmann
Franziska Fuhrmann
RFRandi K. Feist
Randi K. Feist
ALAnnette Lahmann
Annette Lahmann
MBMaysun S. Al Baz
Maysun S. Al Baz
AHAndreas Hutloff
Andreas Hutloff
The co-stimulators ICOS (inducible T cell co-stimulator) and CD28 are both important for T follicular helper (TFH) cells, yet their individual contributions are unclear. Here, we show that each molecule plays an exclusive role at different stages of TFH cell development. While CD28 regulated early expression of the master transcription factor Bcl-6, ICOS co-stimulation was essential to maintain the phenotype by regulating the novel TFH transcription factor Klf2 via Foxo1. Klf2 directly binds to Cxcr5, Ccr7, Psgl-1, and S1pr1, and low levels of Klf2 were essential to maintain this typical TFH homing receptor pattern. Blocking ICOS resulted in relocation of fully developed TFH cells back to the T cell zone and reversion of their phenotype to non-TFH effector cells, which ultimately resulted in breakdown of the germinal center response. Our study describes for the first time the exclusive role of ICOS and its downstream signaling in the maintenance of TFH cells by controlling their anatomical localization in the B cell follicle.

1 July 2018 in Immunity
Verified
Journal Article
Open access
ALAndreia C. Lino
Andreia C. Lino
VDVan Duc Dang
Van Duc Dang
VLVicky Lampropoulou
Vicky Lampropoulou
AWAnna Welle
Anna Welle
JJJara Joedicke
Jara Joedicke
SFSimon Fillatreau
Simon Fillatreau
B lymphocytes can suppress immunity through interleukin (IL)-10 production in infectious, autoimmune, and malignant diseases. Here, we have identified a natural plasma cell subset that distinctively expresses the inhibitory receptor LAG-3 and mediates this function in vivo. These plasma cells also express the inhibitory receptors CD200, PD-L1, and PD-L2. They develop from various B cell subsets in a B cell receptor (BCR)-dependent manner independently of microbiota in naive mice. After challenge they upregulate IL-10 expression via a Toll-like receptor-driven mechanism within hours and without proliferating. This function is associated with a unique transcriptome and epigenome, including the lowest amount of DNA methylation at the Il10 locus compared to other B cell subsets. Their augmented accumulation in naive mutant mice with increased BCR signaling correlates with the inhibition of memory T cell formation and vaccine efficacy after challenge. These natural regulatory plasma cells may be of broad relevance for disease intervention.